Detroit, ME5 Active Studies

Peripheral Artery Disease Clinical Trials in Detroit, ME

Find 5 actively recruiting peripheral artery disease clinical trials in Detroit, ME. Connect with local research sites and explore new treatment options.

5
Active Trials
5
Sponsors
21,212
Enrolling

Recruiting Peripheral Artery Disease Studies in Detroit

About Peripheral Artery Disease Clinical Trials in Detroit

Peripheral artery disease (PAD) is a circulatory condition where narrowed arteries reduce blood flow to the limbs, especially the legs. Common symptoms include leg pain when walking (claudication). Treatment includes lifestyle changes, medications, and sometimes procedures to improve blood flow.

There are currently 5 peripheral artery disease clinical trials recruiting participants in Detroit, ME. These studies are seeking a combined 21,212 participants. Research is being sponsored by Baylor Research Institute, Population Health Research Institute, Cagent Vascular LLC and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Peripheral Artery Disease Clinical Trials in Detroit — FAQ

Are there peripheral artery disease clinical trials in Detroit?

Yes, there are 5 peripheral artery disease clinical trials currently recruiting in Detroit, ME. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Detroit?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Detroit research site will contact you about next steps.

Are clinical trials in Detroit free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Detroit studies also compensate for your time and travel.

What peripheral artery disease treatments are being tested?

The 5 active trials in Detroit are testing new therapies including novel drugs, biologics, and treatment approaches for peripheral artery disease.

Data updated July 13, 2026 from ClinicalTrials.gov